–(HISPANIC PR WIRE)–
ADVISORY for Saturday, August 28
Roche Diagnostics, maker of ACCU-CHEK(R) products is hosting a series of health fairs in the Hispanic community to raise awareness about diabetes and tools to help manage the disease. The Dallas & Ft. Worth health fairs at local grocery stores will feature:
— Bilingual experts from health organizations to offer diabetes education in Spanish
— Dieticians to help patients with diabetes plan healthy meals
— Technicians to conduct blood screenings
— Nurse educators to counsel attendees about diabetes and heart disease
— Representatives from Roche Diagnostics demonstrating ACCU-CHEK(R) products
Diabetes among Hispanic Americans is considered a serious health issue by the National Institutes of Health. Nearly ten percent of all Hispanic Americans have diabetes. On average, Hispanic Americans are nearly two times more likely to have diabetes than non-Hispanic whites of similar age.
Aug. 28, 10 a.m. – 2 p.m. @ Albertsons, 2150 North Josey Lane #400, Carrollton
Ms. Araceli Vazquez, registered dietitian, will be available for media interviews
About Roche Diabetes Care
Roche Diabetes Care has been a pioneer in the development of blood glucose monitoring systems and is a global leader in providing comprehensive diabetes care. This means offering people with diabetes innovative products and services reaching from blood glucose monitoring through data management to insulin delivery. For nearly 30 years, Diabetes Care has been committed to making living easier for people with diabetes and healthcare professionals by providing innovative products and services which make diabetes management easier, more effective and cost efficient.
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world’s leading innovation-driven healthcare groups. Its core businesses are pharmaceuticals and diagnostics. Roche is number one in the global diagnostics market, the leading supplier of pharmaceuticals for cancer and a leader in virology and transplantation. As a supplier of products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche employs roughly 65,000 people in 150 countries. The Group has alliances and research and development agreements with numerous partners, including majority ownership interests in Genentech and Chugai. Roche’s Diagnostics Division, the world leader in in-vitro diagnostics with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. Roche Diagnostics’ North American headquarters are in Indianapolis, Indiana (http://www.roche-diagnostics.us). For further information, please visit our websites http://www.roche.com and http://www.roche-diagnostics.com.
ACCU-CHEK is a trademark of a member of The Roche Group.
Roche Diagnostics Corporation